Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Institut für Versorgungsforschung in der Onkologie | Researchclopedia

Back to institutions

Institut für Versorgungsforschung in der Onkologie

Koblenzfacility

218

Works

2,666

Citations

29

h-index

Top Research Topics

Advanced Breast Cancer Therapies Chronic Lymphocytic Leukemia Research Cancer survivorship and care

Top Researchers

Franz Oesch Boehringer Ingelheim (Germany)

736 works24,530 citationsh-index: 81

Recent Research

Real‐world progression‐free survival and overall survival in patients with <scp>HR</scp> <sup>+</sup> / <scp>HER2</scp> <sup>−</sup> advanced breast cancer treated in first‐line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational <scp>RIBANNA</scp> study

P. Fasching,Cosima Veronika Maria Brucker,et al.

20260 citations

Lymphoma Diagnosis and Treatment

Carcinogens and Genotoxicity Assessment

Breast Cancer Treatment Studies

Psoriasis: Treatment and Pathogenesis

HER2/EGFR in Cancer Research

Brain Metastases and Treatment

Cancer Treatment and Pharmacology

Medical Practices and Rehabilitation

Palliative Care and End-of-Life Issues

W. Dekant University of Würzburg

1,970 works16,093 citationsh-index: 61

Helmut Greim Texas Instruments (Germany)

506 works13,586 citationsh-index: 56

Maya Topf Leibniz Institute of Virology (LIV)

221 works9,766 citationsh-index: 58

Bernd Epe Johannes Gutenberg University Mainz

222 works8,224 citationsh-index: 50

Francisco de León New York University

255 works7,769 citationsh-index: 43

Abstract PS5-04-27: Quality of life in patients with advanced breast cancer (aBC) treated with ribociclib (RIB) in the real-world RIBANNA trial

P. A. Fasching,C. Brucker,et al.

20260 citations

Vulnerability to Infections and Secondary Immunodeficiencies in Patients with Non-Hodgkin’s Lymphomas Starting Anti-CD20 Antibody-Containing Therapies

RUDOLF WEIDE,Johannes Mohm,et al.

20260 citations

Acalabrutinib treatment for older (aged ≥80 years) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial

Florian Simon,Rudy Ligtvoet,et al.

20256 citations

292MO Durvalumab in combination with neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC): Long-term analysis from the GeparNuevo trial

S. Loibl,Michael Untch,et al.

20253 citations

Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study

Thomas Decker,Cosima Brucker,et al.

20251 citations